News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
431,374 Results
Type
Article (31041)
Company Profile (350)
Press Release (399974)
Multimedia
Podcasts (101)
Webinars (12)
Section
Business (114907)
Career Advice (255)
Deals (19897)
Drug Delivery (70)
Drug Development (67884)
Employer Resources (37)
FDA (9470)
Job Trends (7886)
News (209758)
Policy (16796)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1560)
Academic (1)
Accelerated approval (31)
Adcomms (24)
Allergies (110)
Alliances (32876)
ALS (156)
Alzheimer's disease (1295)
Antibody-drug conjugate (ADC) (403)
Approvals (9777)
Artificial intelligence (447)
Autoimmune disease (213)
Automation (18)
Bankruptcy (152)
Best Places to Work (6756)
BIOSECURE Act (8)
Biosimilars (159)
Biotechnology (267)
Bladder cancer (186)
Brain cancer (69)
Breast cancer (730)
Cancer (5611)
Cardiovascular disease (292)
Career advice (234)
Career pathing (11)
CAR-T (307)
CDC (14)
Celiac Disease (1)
Cell therapy (759)
Cervical cancer (43)
Clinical research (58953)
Collaboration (1638)
Company closure (5)
Compensation (890)
Complete response letters (65)
COVID-19 (1429)
CRISPR (99)
C-suite (748)
Cystic fibrosis (117)
Data (6086)
Decentralized trials (1)
Denatured (21)
Depression (117)
Dermatology (43)
Diabetes (322)
Diagnostics (4232)
Digital health (24)
Diversity (8)
Diversity, equity & inclusion (12)
Drug discovery (269)
Drug pricing (84)
Drug shortages (6)
Duchenne muscular dystrophy (257)
Earnings (45648)
Editorial (30)
Employer branding (6)
Employer resources (37)
Events (73390)
Executive appointments (754)
FDA (11980)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (26)
Funding (1323)
Gene editing (204)
Generative AI (36)
Gene therapy (588)
GLP-1 (656)
Government (1967)
Grass and pollen (4)
Guidances (231)
Healthcare (10478)
HIV (38)
Huntington's disease (48)
IgA nephropathy (84)
Immunology and inflammation (253)
Immuno-oncology (87)
Indications (135)
Infectious disease (1603)
Inflammatory bowel disease (186)
Inflation Reduction Act (14)
Influenza (71)
Intellectual property (218)
Interviews (27)
IPO (10057)
IRA (28)
Job creations (1469)
Job search strategy (206)
JPM (52)
Kidney cancer (19)
Labor market (30)
Layoffs (357)
Leadership (11)
Legal (3099)
Liver cancer (105)
Longevity (20)
Lung cancer (758)
Lymphoma (403)
Machine learning (42)
Management (9)
Manufacturing (560)
MASH (157)
Medical device (4829)
Medtech (4855)
Mergers & acquisitions (10676)
Metabolic disorders (952)
mRNA (159)
Multiple sclerosis (133)
NASH (15)
Neurodegenerative disease (307)
Neuropsychiatric disorders (85)
Neuroscience (2438)
Neurotech (1)
NextGen: Class of 2026 (3086)
Non-profit (2152)
Now hiring (41)
Obesity (438)
Opinion (175)
Ovarian cancer (190)
Pain (144)
Pancreatic cancer (268)
Parkinson's disease (295)
Partnered (19)
Patents (421)
Patient recruitment (494)
Peanut (47)
People (36042)
Pharmaceutical (52)
Pharmacy benefit managers (13)
Phase 1 (19789)
Phase 2 (26494)
Phase 3 (18417)
Pipeline (5607)
Policy (147)
Postmarket research (1666)
Preclinical (8348)
Press Release (38)
Prostate cancer (291)
Psychedelics (51)
Radiopharmaceuticals (317)
Rare diseases (843)
Real estate (2568)
Recruiting (14)
Regulatory (15301)
Reports (23)
Research institute (1780)
Resumes & cover letters (25)
Rett syndrome (29)
RNA editing (22)
RSV (35)
Schizophrenia (145)
Series A (233)
Series B (170)
Service/supplier (1)
Sickle cell disease (93)
Special edition (19)
Spinal muscular atrophy (126)
Sponsored (19)
Startups (2526)
State (1)
Stomach cancer (21)
Supply chain (49)
Tariffs (30)
The Weekly (78)
Vaccines (544)
Venture capital (88)
Weight loss (242)
Women's health (60)
Worklife (3)
Date
Last 7 days (481)
Last 30 days (1827)
Last 365 days (22679)
2026 (5902)
2025 (23044)
2024 (26306)
2023 (29152)
2022 (36712)
2021 (38137)
2020 (33339)
2019 (24958)
2018 (18367)
2017 (20713)
2016 (19099)
2015 (22550)
2014 (17061)
2013 (13466)
2012 (13839)
2011 (14048)
2010 (13592)
Location
Africa (290)
Alabama (77)
Alaska (3)
Arizona (131)
Arkansas (8)
Asia (35796)
Australia (5663)
California (9537)
Canada (2508)
China (1173)
Colorado (354)
Connecticut (390)
Delaware (317)
Europe (62122)
Florida (1265)
Georgia (253)
Hawaii (3)
Idaho (24)
Illinois (585)
India (65)
Indiana (315)
Iowa (16)
Japan (439)
Kansas (99)
Kentucky (27)
Louisiana (13)
Maine (17)
Maryland (1055)
Massachusetts (7066)
Michigan (138)
Minnesota (365)
Mississippi (3)
Missouri (67)
Montana (22)
Nebraska (11)
Nevada (62)
New Hampshire (56)
New Jersey (2442)
New Mexico (19)
New York (2552)
North Carolina (1034)
North Dakota (7)
Northern California (4862)
Ohio (230)
Oklahoma (11)
Oregon (30)
Pennsylvania (1592)
Puerto Rico (12)
Rhode Island (29)
South America (403)
South Carolina (13)
Southern California (3685)
Tennessee (82)
Texas (1489)
United States (31936)
Utah (183)
Virginia (205)
Washington D.C. (50)
Washington State (778)
West Virginia (2)
Wisconsin (102)
431,374 Results for "cancer therapeutics crc pty ltd ctx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Adagene Announces Clinical Collaboration with Incyte to Evaluate Muzastotug (ADG126) in Combination with Incyte’s TGFßR2xPD-1 Bispecific Antibody (INCA33890) in Patients with Microsatellite Stable Colorectal Cancer (MSS CRC)
April 2, 2026
·
5 min read
Press Releases
Centauri Therapeutics Granted FDA QIDP Status for CTX-187 Treatment of Gram-Negative Bacterial Infections
March 10, 2026
·
3 min read
Press Releases
Celosia Therapeutics Announces First Patient Dosed in Phase 1b Clinical Trial of CTx1000 in Amyotrophic Lateral Sclerosis
March 24, 2026
·
2 min read
Press Releases
Freenome Delivers Improved Performance in Its Colorectal Cancer Blood Test with Sensitivity of 85% for CRC and 22% for Advanced Precancerous Lesions
January 6, 2026
·
3 min read
Press Releases
Complement Therapeutics Announces FDA Fast Track Designation for CTx001 for the Treatment of Geographic Atrophy Secondary to AMD
January 8, 2026
·
2 min read
Press Releases
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 5, 2025
·
4 min read
Press Releases
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30)
February 18, 2026
·
10 min read
Press Releases
Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients
January 7, 2026
·
2 min read
Press Releases
CRISPR Therapeutics Provides Broad Update on Zugocaptagene Geleucel (Zugo-cel; formerly CTX112™) in Autoimmune Diseases and Hematologic Malignancies
December 23, 2025
·
9 min read
Press Releases
CorriXR Therapeutics, InhaTarget Therapeutics, and Merxin Ltd Announce Strategic Collaboration for the Development of Inhaled Lung Cancer Treatment
December 3, 2025
·
4 min read
1 of 43,138
Next
